Can a Muscle-Zapping device help cirrhosis patients get stronger?

NCT ID NCT07162636

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 2 times

Summary

This study tests whether adding neuromuscular electrical stimulation (NMES) to resistance exercises can improve muscle strength and physical performance in hospitalized patients with alcoholic liver cirrhosis who have muscle loss (sarcopenia). About 112 participants aged 47–70 will be randomly assigned to receive either NMES plus exercise or exercise alone, six times per week during their hospital stay. Researchers will measure handgrip strength and sit-to-stand tests at admission and discharge to see if the combination therapy works better.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

neuromuscular electrical stimulation (NMES) combined with resistance exercise

What this could lead to

If it works, this could provide a better rehabilitation method to help hospitalized patients with alcoholic liver cirrhosis regain muscle strength and reduce hospital readmissions.

What could go wrong

This is a small early-stage trial with only 112 participants, so results may not apply broadly. The intervention is physical therapy, not a drug, so benefits may be modest and depend on patient adherence.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARCOPENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alcoholic liver cirrhosis cirrhosis of liver Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••